CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The IMPROVE-HPV project aims to enhance HPV vaccination coverage in Tanzania and Nigeria by investigating barriers to vaccine uptake and evaluating new delivery strategies, including single-dose regimens and gender-neutral approaches. The project seeks to inform policy decisions to meet global cervical cancer eliminati…
Cervical cancer, caused by human papillomavirus (HPV), is almost entirely preventable through prophylactic HPV vaccination.
Many countries have yet to implement HPV vaccination programmes or are struggling to achieve high vaccine coverage.
This presents a major challenge for meeting the World Health Organisation (WHO) cervical cancer elimination target, with 90% of 15 year-old girls being vaccinated against HPV by 2030.
Originally licenced as multidose vaccines, WHO has recently recommended that…
INSTITUT CATALA D'ONCOLOGIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, L'Hospitalet De Llobregat
Type: Research institute
Activity type: Research Organisations
SME: No
Nigeria, IBADAN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
